For the Inventor, By the Inventor

Enter assignee name

Nyon, Switzerland

Edwards Lifesciences Ag

Calculating rank

USPTO Granted Patents = 52

% Expired Patents = 25.0

CIPO Patents = 11

EPO Patents = 25

Trademarks = 1

Forward Citations = 8,166

Loading Chart...

Loading Chart...

60 inventors (with patents filed for the assignee):

Jan Otto Solem (18 out of 56 patents)

David Alon (8 out of 59 patents)

Derek Dee Deville (7 out of 176 patents)

4. Matthew A Palmer (7 out of 224 patents)

5. M Sean McBrayer (7 out of 37 patents)

6. Richard Cartledge (7 out of 106 patents)

7. Carlos Rivera (7 out of 76 patents)

8. Kevin W Smith (7 out of 274 patents)

9. Max Pierre Mendez (7 out of 20 patents)

10. Thomas O Bales, Jr (7 out of 81 patents)

11. George A Nunez (7 out of 32 patents)

12. Korey R Kline (7 out of 81 patents)

13. Dan Rottenberg (6 out of 57 patents)

14. Judith T Carpenter (6 out of 10 patents)

15. Per Ola Kimblad (6 out of 11 patents)

Core Competencies:

Valve Prosthesis

Embolic Deflection

Mitral Insufficiency

Suture Fixation

Heart Valve Regurgitation

Coronary Sinus Implant

Hemodynamic Monitoring

Annaloplasty System

Heart Geometry Alteration

Blood Flow Control

Tissue Remodeling

Flexible Stent

52 patents: Sort by Forward Citations

1. 12458497 - Method of implanting valve prosthesis having atrial anchoring (2025-11-04),

2. 12364588 - Embolic deflection device (2025-07-22),

3. 12251097 - Multiple-firing suture fixation device and methods for using and manufacturing same (2025-03-18),

4. 11992399 - Embolic deflection device (2024-05-28),

5. 11471150 - Multiple-firing suture fixation device and methods for using and manufacturing same (2022-10-18),

6. 11172924 - Multiple-firing suture fixation device and methods for using and manufacturing same (2021-11-16),

7. 11033389 - Method for replacing a heart valve (2021-06-15),

8. 10786355 - Mitral value prosthesis with atrial anchoring (2020-09-29),

9. 10624630 - Multiple-firing securing device and methods for using and manufacturing same (2020-04-21),

10. 10426591 - Embolic deflection device (2019-10-01),

11. 10405977 - Method for replacing a heart valve (2019-09-10),

12. 10327759 - Multiple-firing suture fixation device and methods for using and manufacturing same (2019-06-25),

13. 10327758 - Multiple-firing suture fixation device and methods for using and manufacturing same (2019-06-25),

14. 10213305 - Device and method for improving heart valve function (2019-02-26),

15. 10016193 - Multiple-firing crimp device and methods for using and manufacturing same (2018-07-10),

Company Overview

Edwards Lifesciences AG, headquartered in Nyon, Switzerland, is a leader in heart valve technology, focusing on innovative solutions for patients with heart valve diseases. The company specializes in the development and manufacturing of advanced valve prostheses and related technologies aimed at addressing conditions such as mitral insufficiency and heart valve regurgitation. Their expertise extends to hemodynamic monitoring and surgical systems, enhancing patient outcomes through precision and reliability in cardiac care.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

52 Patents

#1 in Nyon

#283 in Switzerland

#13,571 in the World

Nyon, Switzerland

Edwards Lifesciences Ag

Forward Citations = 8,166

60 inventors:

Jan Otto Solem (18 out of 56 patents)

David Alon (8 out of 59 patents)

Derek Dee Deville (7 out of 176 patents)

4. Matthew A Palmer (7 out of 224 patents)

5. M Sean McBrayer (7 out of 37 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Edwards Lifesciences Ag. Retrieved from https://idiyas.com/company/edwards-lifesciences-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…